Long-acting analogues of three gut hormones (GLP-1, GIP, and xenin-25) each reduced amyloid burden and restored synaptic markers in Alzheimer's model mice, with liraglutide and GIP analogue also improving cognition.
3 peptides, shared benefitsGLP-1, GIP, and xenin-25 analogues all reduced amyloid and restored synapses, with unique additional effects
What the researchers found
All three gut hormone analogues (GLP-1, GIP, xenin-25) reduced amyloid burden and restored synaptophysin levels, with liraglutide and GIP analogue improving cognition, and xenin-25 uniquely increasing neurogenesis.
Why it matters
Current Alzheimer's treatments offer minimal benefit. The finding that three different gut hormone peptides each reduce Alzheimer's pathology through overlapping and complementary mechanisms supports a multi-peptide therapeutic strategy.
How the study worked
8-10 week treatment study in APP/PS1 transgenic Alzheimer's mice with novel object recognition and Morris water maze testing, immunohistochemistry for amyloid/glia/synapses/neurogenesis, and AD-associated gene expression analysis.
What this study cannot tell us
Mouse model only. APP/PS1 mice don't fully replicate human Alzheimer's. Relatively short treatment period. Long-acting analogues may behave differently in humans.
How to read the evidence
Well-designed preclinical study with behavioral, histological, and transcriptomic endpoints. Strong evidence for further development but animal model limitations.
When this study was published
Published in 2025, advancing the multi-peptide approach to Alzheimer's treatment.
The bigger picture
This suggests Alzheimer's treatment could benefit from targeting multiple gut hormone pathways simultaneously, analogous to how tirzepatide targets GLP-1 and GIP for diabetes. A triple gut hormone approach for neurodegeneration is a novel therapeutic concept.
Questions still open
- Would a triple GLP-1/GIP/xenin agonist produce synergistic neuroprotective effects?
- Can these gut hormone analogues cross the blood-brain barrier in humans?
- Is the Serpina3c pathway a druggable target for Alzheimer's?
Common questions
How could gut hormones help with Alzheimer's?
Is liraglutide being tested for Alzheimer's in humans?
Read the original research
Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.
Neuroscience, 600, 63-81
Citation
Denver, Paul; Duffy, Aisling; Kennedy, Rebecca T; Gault, Victor A; McClean, Paula L. (2026). Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.. Neuroscience, 600, 63-81. https://doi.org/10.1016/j.neuroscience.2026.01.038